神经外科毁损性手术治疗难治性癌痛
OBJECTIVE: Cancer patients suffering from severe refractory pain may benefit from targeted ablative neurosurgical procedures aimed to disconnect pain pathways in the spinal cord or the brain.…
要点
- 局灶性癌痛可选择脊髓疼痛通路离断术,术后即刻缓解率达93%。
- 弥漫性癌痛可选择立体定向扣带回切开术,3个月时64%患者维持良好缓解。
- 严格患者筛选和个体化术式选择下,毁损性手术安全有效。
核心结论
- 在严格患者筛选和根据疼痛综合征个体化选择术式的前提下,神经外科毁损性手术可安全有效地缓解难治性癌痛。
研究设计与样本
- 回顾性研究,纳入2015年3月至2018年4月期间在本院因癌痛接受神经外科手术的全部患者。
临床怎么用
- 对于晚期癌症伴难治性疼痛患者,可根据疼痛分布(局灶性 vs 弥漫性)选择脊髓疼痛通路离断术或立体定向扣带回切开术。
- 术前需经 interdisciplinary clinic 进行严格患者筛选,权衡手术获益与患者整体医疗状况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cancer patients suffering from severe refractory pain may benefit from targeted ablative neurosurgical procedures aimed to disconnect pain pathways in the spinal cord or the brain. These patients often present with a plethora of medical problems requiring careful consideration before surgical interventions. The authors present their experience at an interdisciplinary clinic aimed to facilitate appropriate patient selection for neurosurgical procedures, and the outcome of these interventions. METHODS: This study was a retrospective review of all patients who underwent neurosurgical interventions for cancer pain in the authors' hospital between March 2015 and April 2018. All patients had advanced metastatic cancer with limited life expectancy and suffered from intractable oncological pain. RESULTS: Sixty patients underwent surgery during the study period. Forty-three patients with localized pain underwent disconnection of the spinal pain pathways: 34 percutaneous-cervical and 5 open-thoracic cordotomies, 2 stereotactic mesencephalotomies, and 2 midline myelotomies. Thirty-nine of 42 patients (93%) who completed these procedures had excellent immediate postoperative pain relief. At 1 month the improvement was maintained in 30/36 patients (83%) available for follow-up. There was 1 case of hemiparesis.Twenty patients with diffuse pain underwent stereotactic cingulotomy. Nineteen of these patients reported substantial pain relief immediately after the operation. At 1 month good pain relief was maintained in 13/17 patients (76%) available for follow-up, and good pain relief was also found at 3 months in 7/11 patients (64%). There was no major morbidity or mortality. CONCLUSIONS: With careful patient selection and tailoring of the appropriate procedure to the patient's pain syndrome, the authors' experience indicates that neurosurgical procedures are safe and effective in alleviating suffering in patients with intractable cancer pain.
引用
- Berger A, Hochberg U, Zegerman A, et al. Neurosurgical ablative procedures for intractable cancer pain. J Neurosurg. 2019. PMID: 31075782. doi:10.3171/2019.2.JNS183159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。